Business Context and Reporting Period
This Form 10-QSB covers the quarterly period ended June 30, 2005, for Orthodontix, Inc. (Note: The input metadata referenced Protalix Biotherapeutics, but the filing text explicitly identifies the issuer as Orthodontix, Inc.). The Company is a shell entity that terminated its affiliation with its founding orthodontic practices in 2001. It currently has no active operating business and is devoting its resources to identifying and consummating a merger or acquisition with an operating company.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2005 | Six Months Ended June 30, 2005 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(12,776) | $(23,135) |
| Loss Per Share (Basic & Diluted) | $(0.00) | $(0.01) |
| General & Administrative Expenses | $20,445 | $31,308 |
| Interest and Other Income | $7,669 | $8,173 |
| Cash and Cash Equivalents (End of Period) | $515,153 | |
| Total Liabilities | $57,785 | |
| Accumulated Deficit | $(3,760,887) | |
| Shares Outstanding | 2,915,428 |
Material Changes vs. Prior Period
- Net Loss Reduction: The net loss for the three months ended June 30, 2005, decreased significantly to $(12,776) compared to $(58,543) in the same period in 2004. Similarly, the six-month net loss decreased to $(23,135) from $(85,236) in the prior year.
- Expense Reduction: General and administrative expenses dropped to $20,445 for the quarter (from $59,908 in 2004) and $31,308 for the six months (from $89,592 in 2004).
- Income Increase: Total other income increased to $7,669 for the quarter (from $1,365 in 2004), driven primarily by interest income and other income.
- Cash Flow: Net cash used in operating activities for the six months ended June 30, 2005, was $(48,559), a significant improvement compared to $(109,695) in the prior year period.
Outlook, Risks, and Management Commentary
- Plan of Operation: Management intends to continue seeking a business combination with an operating company in industries such as aircraft maintenance, health care, pharmaceuticals, or financial services. No specific target or contractual commitment exists.
- Liquidity: The Company holds approximately $515,200 in cash, primarily in money market accounts. Management believes this is sufficient to fund operations for at least the next twelve months.
- Risks: There is no assurance that the Company will successfully consummate a merger or acquisition, or that the combined entity would be profitable. The Company has an accumulated deficit of over $3.7 million.
- Controls: Management concluded that disclosure controls and procedures were effective as of June 30, 2005, with no significant changes in internal controls.
- Legal Proceedings: None reported.
Investor Verification Checklist
- Verify the Company's current cash balance of ~$515k against recent bank statements to confirm liquidity runway.
- Confirm the absence of any undisclosed agreements or negotiations regarding a potential merger or acquisition.
- Review the "Accumulated Deficit" of $3.76M to understand the historical capital consumption.
- Check for any new filings (8-K) post-August 9, 2005, regarding changes in management or strategic direction.
- Validate the concentration risk regarding bank deposits, noting $378,455 was held in excess of federally insured limits.